Bala Başak Öven, S. Çelik, G. Gürleyik, F. Vardar, E. Çoban, M. Seker, I. Okten, A. Aktekin
aDepartment of Medical Oncology, Bahçeşehir University Medical Faculty, İstanbul, TURKEY bDepartment of General Surgery, Haydarpasa Numune Educartion and Research Hospital, İstanbul, TURKEY cDepartment of Pathology, Haydarpasa Numune Educartion and Research Hospital, İstanbul, TURKEY dDepartment of Medical Oncology, Bezmi Alem University, Medical Faculty, İstabul,TURKEY eDepartment of General Surgey Gaziantep University, Medical Faculty, Gaziantep, TURKEY
{"title":"Benefits of Neoadjuvant Chemotherapy for Luminal Breast Cancer with Respect to Tumor Response","authors":"Bala Başak Öven, S. Çelik, G. Gürleyik, F. Vardar, E. Çoban, M. Seker, I. Okten, A. Aktekin","doi":"10.37047/JOS.2020-75852","DOIUrl":"https://doi.org/10.37047/JOS.2020-75852","url":null,"abstract":"aDepartment of Medical Oncology, Bahçeşehir University Medical Faculty, İstanbul, TURKEY bDepartment of General Surgery, Haydarpasa Numune Educartion and Research Hospital, İstanbul, TURKEY cDepartment of Pathology, Haydarpasa Numune Educartion and Research Hospital, İstanbul, TURKEY dDepartment of Medical Oncology, Bezmi Alem University, Medical Faculty, İstabul,TURKEY eDepartment of General Surgey Gaziantep University, Medical Faculty, Gaziantep, TURKEY","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"7 1","pages":"7-14"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69817983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
become the most common malignant disease, with two million new cases and more than 600,000 deaths in 2018, making it vital to identify the associated risk factors.1,2 Many earlier studies have attempted to assess an association between thyroid disease and breast cancer, but it is difficult to distinguish a cause-and-effect relationship between the two conditions despite their high prevalence in women.3 The relation between hypothyroidism and the risk of breast cancer was first published in 1976 by Kapdi and Wolfe, who observed a higher breast cancer incidence rate among patients undergoing thyroid supplement treatment.4 Since then, four metaanalyses have studied thyroid dysfunction and the risk of breast cancer.5-8 Angelousi et al. examined 12 studies and found no association between hypothyroidism and increased risk of breast cancer, five and further suggested that thyroid hormone replacement therapy did not reduce the prevalence of breast cancer. In a later metaanalysis, Fang et al. reported no relationship between thyroid dysfunction and risk of breast cancer, while Wang et al. found a reduced risk of breast cancer due to hypothyroidism in the European population.7,8
{"title":"Subclinical Hypothyroidism in Patients with Newly Diagnosed Breast Cancer","authors":"M. Kara, Oyku Beyaz, E. Koç, O. Sonmez","doi":"10.37047/JOS.2020-79561","DOIUrl":"https://doi.org/10.37047/JOS.2020-79561","url":null,"abstract":"become the most common malignant disease, with two million new cases and more than 600,000 deaths in 2018, making it vital to identify the associated risk factors.1,2 Many earlier studies have attempted to assess an association between thyroid disease and breast cancer, but it is difficult to distinguish a cause-and-effect relationship between the two conditions despite their high prevalence in women.3 The relation between hypothyroidism and the risk of breast cancer was first published in 1976 by Kapdi and Wolfe, who observed a higher breast cancer incidence rate among patients undergoing thyroid supplement treatment.4 Since then, four metaanalyses have studied thyroid dysfunction and the risk of breast cancer.5-8 Angelousi et al. examined 12 studies and found no association between hypothyroidism and increased risk of breast cancer, five and further suggested that thyroid hormone replacement therapy did not reduce the prevalence of breast cancer. In a later metaanalysis, Fang et al. reported no relationship between thyroid dysfunction and risk of breast cancer, while Wang et al. found a reduced risk of breast cancer due to hypothyroidism in the European population.7,8","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"7 1","pages":"15-19"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69819770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
(TIAPs) are reported to be safe and well-accepted among cancer patients.1 TIAPs are useful in the management of patients who require multiple chemotherapy sessions, parenteral nutrition, prolonged intravenous drug treatment (with antibiotics, etc.), and repeated drawing of blood. Moreover, chemotherapeutic agents are associated with less venous toxicity when administered via the central venous route. Most cases of TIAPs remain complication-free until treatment completion or death and present a complication rate of 19% during the entire duration of device usage.1 In the case report presented here, a rare complication of TIAPs-peri-catheter fibrin sheath calcification mimicking a retained catheter fragment-is described to increase the awareness of this condition among medical professionals.
{"title":"Pericatheter Fibrin Sheath Calcification Mimicking Retained Catheter Fragment","authors":"F. Çay, G. Eldem, B. Peynircioğlu","doi":"10.37047/jos.2020-80449","DOIUrl":"https://doi.org/10.37047/jos.2020-80449","url":null,"abstract":"(TIAPs) are reported to be safe and well-accepted among cancer patients.1 TIAPs are useful in the management of patients who require multiple chemotherapy sessions, parenteral nutrition, prolonged intravenous drug treatment (with antibiotics, etc.), and repeated drawing of blood. Moreover, chemotherapeutic agents are associated with less venous toxicity when administered via the central venous route. Most cases of TIAPs remain complication-free until treatment completion or death and present a complication rate of 19% during the entire duration of device usage.1 In the case report presented here, a rare complication of TIAPs-peri-catheter fibrin sheath calcification mimicking a retained catheter fragment-is described to increase the awareness of this condition among medical professionals.","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69819783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
106 Smoking is still the most important cause of morbidity and mortality in Turkey and the world. Smoking is a severe problem in cancer patients and should be handled effectively. Studies have reported that cancer-specific mortality increases in cancer patients who continue smoking and that quitting smoking at any stage after diagnosis is beneficial in treatment outcomes, quality of life, and general survival of patients with cancer.1-5
{"title":"Evaluation of Smoking Status of Cancer Patients Admitted to the Nuclear Medicine Department According to the Demographic Characteristics and Cancer Type","authors":"S. Göksel, D. Karadoğan","doi":"10.37047/jos.2021-84128","DOIUrl":"https://doi.org/10.37047/jos.2021-84128","url":null,"abstract":"106 Smoking is still the most important cause of morbidity and mortality in Turkey and the world. Smoking is a severe problem in cancer patients and should be handled effectively. Studies have reported that cancer-specific mortality increases in cancer patients who continue smoking and that quitting smoking at any stage after diagnosis is beneficial in treatment outcomes, quality of life, and general survival of patients with cancer.1-5","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"60 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69820923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Sanlier, M. Şahin, A. Demirkazık, Asiye Özkan, F. Senler
apeutics may lead to the development of various functional problems among the patients. Novel surgical procedures developed to protect organ function employ minimally invasive procedures. However, complex therapies including radiotherapy and chemotherapy are often provided to the patients. Multidisciplinary treatment approaches in cancer patients affect a number of functional fields including physical, psychosocial, and economic areas.1
{"title":"Sleep Quality of Cancer Patients Receiving Systemic Treatment: A Cross-Sectional Study","authors":"N. Sanlier, M. Şahin, A. Demirkazık, Asiye Özkan, F. Senler","doi":"10.37047/jos.2019-71898","DOIUrl":"https://doi.org/10.37047/jos.2019-71898","url":null,"abstract":"apeutics may lead to the development of various functional problems among the patients. Novel surgical procedures developed to protect organ function employ minimally invasive procedures. However, complex therapies including radiotherapy and chemotherapy are often provided to the patients. Multidisciplinary treatment approaches in cancer patients affect a number of functional fields including physical, psychosocial, and economic areas.1","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"6 1","pages":"15-22"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69817520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
combination of MEK inhibitors (cobimetinib and trametinib), and BRAF inhibitors (vemurafenib and dabrafenib) is now considered as the first-line treatment of patients with BRAF V600-mutated metastatic melanoma. The common side-effects of BRAF inhibitors are cutaneous toxicity, nephrotoxicity, and cardiotoxicity.1 In a previous clinical study, the combined administration of vemurafenib and cobimetinib has been associated with cardiotoxicity (heart failure) and QTc prolongation, that persisted after the discontinuation of therapy but returned to normal after six months. The patient was discharged with an implantable intracardiac defibrillator (ICD) for safety.2 Most TKIs significantly increase the QT interval, while the incidence of arrhythmias was noted highest in vemurafenib.3 Additionally, vemurafenib might induce severe acute renal failure, including persistent renal injury.4 Though, the result from the previous clinical study which was based on 38 patients, showed that the adjunction of MEK inhibitor to vemurafenib in the treatment of metastatic melanoma reduces the incidence and severity of nephrotoxicity compared to monotherapy in a study of 38 patients, while a phase IB dose-escalation study of the cobimetinib and duligotuzumab showed that the 26% of the patients experienced hypokalemia, further indicating cobimetinib which might have some adverse effects on the renal tubular system.5,6 J Oncol Sci.2020;6(2):123-6
{"title":"Deciphering the Role of Combination Therapy of Cobimetinib, Vemurafenib, and Antidepressant Drugs in QTc Prolongation and Torsade De Pointes (TDP) in Malignant Melanoma","authors":"A. Paudel, O. Mammadov, Özlem Sönmez","doi":"10.37047/jos.2020-73730","DOIUrl":"https://doi.org/10.37047/jos.2020-73730","url":null,"abstract":"combination of MEK inhibitors (cobimetinib and trametinib), and BRAF inhibitors (vemurafenib and dabrafenib) is now considered as the first-line treatment of patients with BRAF V600-mutated metastatic melanoma. The common side-effects of BRAF inhibitors are cutaneous toxicity, nephrotoxicity, and cardiotoxicity.1 In a previous clinical study, the combined administration of vemurafenib and cobimetinib has been associated with cardiotoxicity (heart failure) and QTc prolongation, that persisted after the discontinuation of therapy but returned to normal after six months. The patient was discharged with an implantable intracardiac defibrillator (ICD) for safety.2 Most TKIs significantly increase the QT interval, while the incidence of arrhythmias was noted highest in vemurafenib.3 Additionally, vemurafenib might induce severe acute renal failure, including persistent renal injury.4 Though, the result from the previous clinical study which was based on 38 patients, showed that the adjunction of MEK inhibitor to vemurafenib in the treatment of metastatic melanoma reduces the incidence and severity of nephrotoxicity compared to monotherapy in a study of 38 patients, while a phase IB dose-escalation study of the cobimetinib and duligotuzumab showed that the 26% of the patients experienced hypokalemia, further indicating cobimetinib which might have some adverse effects on the renal tubular system.5,6 J Oncol Sci.2020;6(2):123-6","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"6 1","pages":"123-126"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69817535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Sümbül, Ş. Yalçın, A. Özet, S. Ünal, O. Dizdar, H. Akbulut, A. Karaoglu, N. Karadurmuş, M. Şendur, E. Çılbır, F. Yıldız, G. Tufan, O. Sonmez, N. Turhal
monia in Wuhan province in China in December 2019 and later caused a pandemic in the whole world, is a serious threat to all humans and particularly, the oncology patients.1 With the diagnosis of the first case in our country and the declaration by WHO of COVID19 as a global pandemic on March 11, 2020, a new phase of the process has begun. WHO particularly emphasizes the preparedness, prevention, case detection, treatment, and reduction of transmission related to the basic strategies of the disease.2 Cancer patients are at high mortality risk due to coronavirus infection because of age, comorbid conditions, and current use of immunosuppressive treatment protocols.
{"title":"Turkish Medical Oncology Society COVID-19 Pandemic Advisory Board Recommendations for Cancer Patients and Medical Oncologist","authors":"A. Sümbül, Ş. Yalçın, A. Özet, S. Ünal, O. Dizdar, H. Akbulut, A. Karaoglu, N. Karadurmuş, M. Şendur, E. Çılbır, F. Yıldız, G. Tufan, O. Sonmez, N. Turhal","doi":"10.37047/jos.2020-75364","DOIUrl":"https://doi.org/10.37047/jos.2020-75364","url":null,"abstract":"monia in Wuhan province in China in December 2019 and later caused a pandemic in the whole world, is a serious threat to all humans and particularly, the oncology patients.1 With the diagnosis of the first case in our country and the declaration by WHO of COVID19 as a global pandemic on March 11, 2020, a new phase of the process has begun. WHO particularly emphasizes the preparedness, prevention, case detection, treatment, and reduction of transmission related to the basic strategies of the disease.2 Cancer patients are at high mortality risk due to coronavirus infection because of age, comorbid conditions, and current use of immunosuppressive treatment protocols.","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"1 1","pages":"1-4"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69817690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Ayhan, I. Çiçin, A. Gökyer, M. Sarı, A. Turan, S. Taşkın, K. Gungorduk, O. Akbayir, P. Saip, H. Şahin, G. Çoban, S. Topuz, I. Selcuk, G. Tulunay, M. Meydanlı
78 Ovarian carcinosarcoma (OCS), accounting for only 1-4% of all ovarian malignancies, is a rare neoplasm characterized by sarcomatous and epithelial elements.1-3 Some authors have proposed that OCSs originate from the müllerian epithelium and then differentiation/metaplasia to a sarcomatous structure, supporting the hypothesis that OCS is a metaplastic epithelial carcinoma.4-6 OCS is highly aggressive and has a poor prognosis, presenting with a disease that has spread beyond the ovary in up to 90% of cases at Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study
{"title":"Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study","authors":"A. Ayhan, I. Çiçin, A. Gökyer, M. Sarı, A. Turan, S. Taşkın, K. Gungorduk, O. Akbayir, P. Saip, H. Şahin, G. Çoban, S. Topuz, I. Selcuk, G. Tulunay, M. Meydanlı","doi":"10.37047/jos.2019-73073","DOIUrl":"https://doi.org/10.37047/jos.2019-73073","url":null,"abstract":"78 Ovarian carcinosarcoma (OCS), accounting for only 1-4% of all ovarian malignancies, is a rare neoplasm characterized by sarcomatous and epithelial elements.1-3 Some authors have proposed that OCSs originate from the müllerian epithelium and then differentiation/metaplasia to a sarcomatous structure, supporting the hypothesis that OCS is a metaplastic epithelial carcinoma.4-6 OCS is highly aggressive and has a poor prognosis, presenting with a disease that has spread beyond the ovary in up to 90% of cases at Optimal Cytoreduction is an Independent Prognostic Factor in Ovarian Carcinosarcoma: A Turkish Gynecologic Oncology Group Study","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"6 1","pages":"78-86"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69817614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lung cancer, which was described as “one of the rarest forms of cancer” in 1912 before the introduction of cigarettes, was the most common diagnosed cancer in 2018 (2.1 million, 11.6% of the total). Lung cancer needs to be considered as it is the most common cause of death (1.8 million, 18.4% of the total).1 Although several developed nations now have declining rates of lung cancer, the incidence and mortality rates among women have increased in several western countries. Although the incidence of lung cancer decreased among men, an increasing pattern was noted among women, which was associated with increased smoking rates after the second J Oncol Sci.2020;6(1):29-34
{"title":"Epidemiology of Lung Cancer in Women: A Hospital-Based Descriptive Study","authors":"Ö. Er, Didem Saka, Elif Özuğuz","doi":"10.37047/jos.2020-73409","DOIUrl":"https://doi.org/10.37047/jos.2020-73409","url":null,"abstract":"Lung cancer, which was described as “one of the rarest forms of cancer” in 1912 before the introduction of cigarettes, was the most common diagnosed cancer in 2018 (2.1 million, 11.6% of the total). Lung cancer needs to be considered as it is the most common cause of death (1.8 million, 18.4% of the total).1 Although several developed nations now have declining rates of lung cancer, the incidence and mortality rates among women have increased in several western countries. Although the incidence of lung cancer decreased among men, an increasing pattern was noted among women, which was associated with increased smoking rates after the second J Oncol Sci.2020;6(1):29-34","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"26 1","pages":"29-34"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69817426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Alkan, H. S. Öztorun, E. Karci, Y. Urun, G. Tuncay, A. Yaşar, E. Çınar, S. Aras, M. Varlı, G. Utkan, A. Demirkazık, H. Akbulut, F. Senler
experience or feeling that results from inadequacies in personal or social requirements. It principally originates from differences between the desired and actual social relations.1 Its prevalence increases linearly with age, and thus, is found in up to 50% of geriatric patients.2 Geriatric patients are more exposed to loneliness; hence, this subject has been studied more extensively in the geriatric patient group. Female geriatric patients have been documented to be at higher risk of loneliness due to factors such as being single/widowed, older age, low educational status, low household income, living alone, decreased quality of social interactions, poor health, and decreased functional status.3 In addition, the presence of depression has been associated with increased loneliness.4,5 Studies on the clinical effects of loneliness on geriatric patients have shown that loneliness is associated with mental health issues, reduced sleep quality, decreased quality of life, increased hospitalizations, and increased mortality.6-9 In addition, loneliness has been associated with cognitive dysfunction and Alzheimer’s disease.10-13 J Oncol Sci.2020;6(2):65-70
{"title":"The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients","authors":"A. Alkan, H. S. Öztorun, E. Karci, Y. Urun, G. Tuncay, A. Yaşar, E. Çınar, S. Aras, M. Varlı, G. Utkan, A. Demirkazık, H. Akbulut, F. Senler","doi":"10.37047/jos.2019-71889","DOIUrl":"https://doi.org/10.37047/jos.2019-71889","url":null,"abstract":"experience or feeling that results from inadequacies in personal or social requirements. It principally originates from differences between the desired and actual social relations.1 Its prevalence increases linearly with age, and thus, is found in up to 50% of geriatric patients.2 Geriatric patients are more exposed to loneliness; hence, this subject has been studied more extensively in the geriatric patient group. Female geriatric patients have been documented to be at higher risk of loneliness due to factors such as being single/widowed, older age, low educational status, low household income, living alone, decreased quality of social interactions, poor health, and decreased functional status.3 In addition, the presence of depression has been associated with increased loneliness.4,5 Studies on the clinical effects of loneliness on geriatric patients have shown that loneliness is associated with mental health issues, reduced sleep quality, decreased quality of life, increased hospitalizations, and increased mortality.6-9 In addition, loneliness has been associated with cognitive dysfunction and Alzheimer’s disease.10-13 J Oncol Sci.2020;6(2):65-70","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"6 1","pages":"65-70"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69817464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：